We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.5B
AUM Growth
-$1.93B
(-10%)
Cap. Flow
-$2.26B
Cap. Flow
% of AUM
-13.67%
Top 10 Holdings %
Top 10 Hldgs %
16.19%
Holding
1,547
New
416
Increased
366
Reduced
319
Closed
426
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$233M |
| 2 |
TSMC
TSM
|
+$222M |
| 3 |
Philip Morris
PM
|
+$189M |
| 4 |
Qualcomm
QCOM
|
+$171M |
| 5 |
AstraZeneca
AZN
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$396M |
| 2 |
Citigroup
C
|
+$269M |
| 3 |
Cisco
CSCO
|
+$253M |
| 4 |
Boeing
BA
|
+$166M |
| 5 |
Bank of America
BAC
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.96% |
| 2 | Technology | 21.61% |
| 3 | Consumer Staples | 8.79% |
| 4 | Communication Services | 8.54% |
| 5 | Financials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRGA
1026
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $341K | ﹤0.01% |
+2,789
| New | +$302K |
|
|
MWW
1027
DELISTED
Monster Worldwide Inc
MWW
| $340K | ﹤0.01% |
45,400
-529,090
| -92% | -$3.82M |
|
|
CPE
1028
DELISTED
Callon Petroleum Company
CPE
| $339K | ﹤0.01% |
+4,050
| New | +$286K |
|
1029
B&G Foods
BGS
$272M
| $336K | ﹤0.01% |
+11,166
| New | +$350K |
|
|
MSCC
1030
DELISTED
Microsemi Corp
MSCC
| $334K | ﹤0.01% |
+13,355
| New | +$322K |
|
1031
Strategy Inc
MSTR
$37.1B
| $333K | ﹤0.01% |
28,860
-46,010
| -61% | -$575K |
|
1032
Nu Skin
NUS
$255M
| $331K | ﹤0.01% |
+3,997
| New | +$351K |
|
1033
Banco Santander Chile
BSAC
$16.7B
| $330K | ﹤0.01% |
+14,060
| New | +$305K |
|
1034
Federal Agricultural Mortgage
AGM
$2.54B
| $321K | ﹤0.01% |
+9,657
| New | +$305K |
|
|
NWY
1035
DELISTED
New York & Co Inc
NWY
| $318K | ﹤0.01% |
72,444
-36,428
| -33% | -$163K |
|
|
PES
1036
DELISTED
Pioneer Energy Services Corp.
PES
| $314K | ﹤0.01% |
+24,215
| New | +$242K |
|
|
DOC
1037
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $314K | ﹤0.01% |
22,586
-2,520
| -10% | -$32.8K |
|
|
COWN
1038
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $303K | ﹤0.01% |
+17,160
| New | +$283K |
|
|
CWEI
1039
DELISTED
Clayton Williams Energy, Inc.
CWEI
| $302K | ﹤0.01% |
+2,668
| New | +$227K |
|
|
RNWK
1040
DELISTED
RealNetworks Inc
RNWK
| $301K | ﹤0.01% |
39,698
-3,634
| -8% | -$27.4K |
|
1041
Kforce
KFRC
$1.03B
| $300K | ﹤0.01% |
14,090
-10,226
| -42% | -$209K |
|
1042
Medallion Financial
MFIN
$247M
| $298K | ﹤0.01% |
+22,570
| New | +$313K |
|
|
MPO
1043
DELISTED
MIDSTATES PETE CO INC COM NEW
MPO
| $298K | ﹤0.01% |
+5,562
| New | +$291K |
|
1044
First Merchants
FRME
$2.66B
| $296K | ﹤0.01% |
13,685
+466
| +4% | +$9.88K |
|
1045
CoreCivic
CXW
$3.3B
| $288K | ﹤0.01% |
+9,186
| New | +$303K |
|
1046
Spok Holdings
SPOK
$236M
| $288K | ﹤0.01% |
15,856
-8,959
| -36% | -$133K |
|
|
1047
Citigroup
C
$228B
| $283K | ﹤0.01% |
5,946
-5,403,927
| -100% | -$269M |
|
|
CDR
1048
DELISTED
Cedar Realty Trust, Inc
CDR
| $283K | ﹤0.01% |
+7,013
| New | +$290K |
|
|
OME
1049
DELISTED
Omega Protein
OME
| $283K | ﹤0.01% |
+23,455
| New | +$269K |
|
|
N
1050
DELISTED
Netsuite Inc
N
| $282K | ﹤0.01% |
+2,974
| New | +$317K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2014 Portfolio in Review
As of Q1 2014, Arrowstreet Capital held 1,547 positions worth $16.5B, down 10% from $18.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Arrowstreet Capital withdrew a net $2.26B in Q1 2014, closing 426 positions and reducing 319 holdings. Its most notable exit was GE Aerospace, an estimated $151M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Arrowstreet Capital opened a new position in Philip Morris worth $192M.
- Arrowstreet Capital's largest Q1 2014 buy was Philip Morris: 2,344,576 shares worth $192M.
- Arrowstreet Capital added most to GSK in Q1 2014, an estimated $233M increase.
- Arrowstreet Capital's biggest Q1 2014 reduction was Vodafone, cutting an estimated $396M.
- Arrowstreet Capital fully exited GE Aerospace in Q1 2014, selling an estimated $151M.
- Arrowstreet Capital's ten largest holdings make up 16% of its $16.5B portfolio in Q1 2014.
- Arrowstreet Capital opened 416 new positions and closed 426 in Q1 2014.
- Arrowstreet Capital's portfolio value fell 10% quarter-over-quarter to $16.5B.
Based on Arrowstreet Capital's 13F filing for Q1 2014, filed 15 May 2014.